Literature DB >> 2765674

Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate.

R Suzuki1, H Toda, Y Takamura.   

Abstract

Blood coagulation studies were performed in twenty patients with ulcerative colitis (UC). At the active stage of UC, a marked increase in platelet count and fibrinogen concentration, and a marked decrease in Factor XIII activity level were observed. At the active stage of UC, four patients were treated with Factor XIII concentrate leading to reduction of pain, bleeding and endoscopic findings.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2765674     DOI： 10.1007/BF00320061

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


  6 in total

1.  Coagulation studies in ulcerative colitis and Crohn's disease.

Authors:  A Lam; I T Borda; M J Inwood; S Thomson
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

2.  Reduced levels of factor XIII in patients with chronic inflammatory bowel disease.

Authors:  M J Galloway; M J Mackie; B A McVerry
Journal:  Clin Lab Haematol       Date:  1983

3.  A new rapid and simple assay for factor XIII activity using dansylcadaverine incorporation and gel filtration.

Authors:  Y Nishida; S Ikematsu; K Fukutake; M Fujimaki; K Fukutake; E Kakishita
Journal:  Thromb Res       Date:  1984-10-15       Impact factor: 3.944

4.  Factor XIII deficiency in antibiotic-associated pseudomembranous colitis and its treatment with factor XIII concentrate.

Authors:  T Kuratsuji; T Oikawa; T Fukumoto; S Shimizu; Y Iwasaki; Y Tomita; T Meguro; K Yamada
Journal:  Haemostasis       Date:  1982

5.  Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects.

Authors:  R Egbring; W Schmidt; G Fuchs; K Havemann
Journal:  Blood       Date:  1977-02       Impact factor: 22.113

6.  No evidence for a prethrombotic state in stable chronic inflammatory bowel disease.

Authors:  E Knot; J W Ten Cate; O C Leeksma; G N Tytgat; J Vreeken
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411
  6 in total
  4 in total

1.  Factor XIIIA subunit and Crohn's disease.

Authors:  M Hudson; A J Wakefield; R A Hutton; E A Sankey; A P Dhillon; L More; R Sim; R E Pounder
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

2.  Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis.

Authors:  Christina Andersson; Peter H Kvist; Kathryn McElhinney; Richard Baylis; Luise K Gram; Hermann Pelzer; Brian Lauritzen; Thomas L Holm; Simon Hogan; David Wu; Brian Turpin; Whitney Miller; Joseph S Palumbo
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

3.  Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study.

Authors:  Karsten Bernerth; Ingolf Schiefke; Karin Liebscher; Susanne Raczynski; Tanja Kottmann; Niels Teich
Journal:  BMC Res Notes       Date:  2018-12-04

Review 4.  The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing.

Authors:  Christian Kleber; Armin Sablotzki; Sebastian Casu; Martin Olivieri; Kai-Martin Thoms; Johannes Horter; Felix C F Schmitt; Ingvild Birschmann; Dietmar Fries; Marc Maegele; Herbert Schöchl; Michaela Wilhelmi
Journal:  Crit Care       Date:  2022-03-24       Impact factor: 19.334
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.